425: Strive & Semler Scientific Announce Merger Plans

Strive, Inc. and Semler Scientific, Inc. announced a proposed business combination, with Strive filing a Form S-4 registration statement.

Summary

• Strive, Inc. and Semler Scientific, Inc. are pursuing a proposed business combination.
• The communication was posted on X.com by Matthew Cole, Chief Executive Officer of Strive, Inc., on September 24, 2025.
• The filing serves as a cautionary statement regarding forward-looking statements related to the proposed transaction.
• Strive intends to file a Registration Statement on Form S-4 with the SEC to register Class A common stock to be issued in connection with the merger.
• The Registration Statement will include an information statement of Strive, a proxy statement of Semler Scientific, and a prospectus of Strive.
• Stockholders of Semler Scientific will be sent a definitive Information Statement/Proxy Statement/Prospectus to seek their approval of the proposed transaction.

Sentiment

Score: 5

Explanation: The filing announces a proposed business combination and provides extensive cautionary statements regarding forward-looking information and associated risks, maintaining a neutral tone without presenting specific financial results.

Positives

• Anticipated strategic benefits of the proposed transaction.
• Expected financial benefits of the proposed transaction, including impact on the combined company's future financial performance.
• The ability to successfully integrate the combined businesses.

Negatives

• The possibility that anticipated benefits, including cost savings and strategic gains, may not be realized.
• Integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated.
• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock.
• Potential adverse reactions from Strive's or Semler Scientific's customers or changes to business or employee relationships.
• Changes in Strive's or Semler Scientific's share price before closing.

Risks

• The occurrence of any event, change, or other circumstances that could give rise to the right of one or both companies to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because conditions to closing are not received or satisfied.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• Anticipated benefits of the proposed transaction, including cost savings and strategic gains, may not be realized when expected or at all.
• Risks associated with changes in, or problems arising from, implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement could impact results.
• Integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated due to unexpected factors or events.
• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other factors that may affect future results of Strive, Semler Scientific, or the combined company, including unknown or unpredictable factors.

Future Outlook

The outlook and expectations of Strive and Semler Scientific are focused on the proposed transaction, including anticipated strategic and financial benefits, the timing of the closing, and the ability to successfully integrate the combined businesses. These are forward-looking statements subject to inherent risks and uncertainties.

Management Comments

• Matthew Cole, Chief Executive Officer of Strive, Inc., communicated about the proposed business combination with Semler Scientific, Inc. on X.com.

Industry Context

This announcement is specific to the proposed business combination between Strive, Inc. and Semler Scientific, Inc. and does not provide broader industry trends or competitor analysis within this filing.

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company is a potential risk.

Stakeholder Impact

• Potential adverse reactions of Strive's or Semler Scientific's customers.
• Changes to business or employee relationships.
• Dilution for Strive's Class A common stock shareholders due to additional share issuance in connection with the proposed transaction.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to the stockholders of Semler Scientific.
• Semler Scientific stockholders will be urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus and other relevant documents before making any voting or investment decision.
• Semler Scientific stockholders will vote on the proposed transaction.

Key Dates

Keywords

Strive Inc., Semler Scientific Inc., Merger, Business Combination, SEC Filing, Form 425, Bitcoin Treasury, Acquisition, Corporate Governance